Carolina Mammography Registry
130 Mason Farm Rd.
Bioinformatics Building, CB#7515
Chapel Hill, NC 27599
(919) 966-0492
 

 

Data Collection Variables

Patient Demographic and Health History Data

    • Demographic Variables
      • Unique identification number
      • Zip code
      • Date of birth
      • Race (white, black, Asian or Pacific Islander, Native American, other); ethnicity (Hispanic)
      • Education (less than high school, high school/GED, some college, college or post-college grad
      • Health insurance (Medicare, Medicaid, other, none)
    • Health History
      • First-degree family history of breast cancer (mother, sister, daughter) and age: <50, >50
      • Personal history of breast cancer (yes, no)
      • Personal history of breast biopsy, surgery, or radiation (yes, no)
      • Procedure history per breast (implants, needle biopsy, surgical biopsy, lumpectomy, mastectomy, radiation therapy, and reconstruction)
    • Screening History
      • Ever screened by mammography (yes, no)
      • Time since last mammogram
    • Current Health
      • Menstrual periods, stopped due to surgery?
      • Hormone use at time of examination; type of hormones, length of use
      • Ovaries removed, number removed
      • Height/Weight
      • Presence of symptoms in last 3 months (pain, nipple discharge or lump; right or left breast)
    • Radiologic Site and Interpreting Mammographer Identification
      • Variables are encrypted to protect confidentiality.
    • Dates of Current Examination and Comparison Film
    • Use of Comparison Mammogram at Time of Evaluation (yes, no)
    • Indication for Examination
      • Screening (asymptomatic), evaluation of breast problem (symptomatic), additional evaluation of recent mammogram, short interval follow-up
    • Type of Examination(s) Performed
      • Standard screening views, additional diagnostic views, sonography, other breast imaging
  • Palpable Masses
    • Breast Density (American College of Radiology lexicon)
      • Entirely fat, scattered fibroglandular densities, heterogeneously dense, extremely dense
    • Assessment per Woman
      • Incomplete assessment, normal, normal with benign finding, probably benign, suspicious abnormality, highly suggestive for malignancy
  • Mammographic Findings (calcifications, assymmetry, masses, architectural distortion)
    • Recommendation
      • Mammography in normal interval follow-up, additional views, sonography, short-term follow-up, fine-needle aspiration, core biopsy, consider biopsy or surgical evaluation, clinical evaluation for further diagnostic evaluation

Follow-Up Data

    • Follow-Up Performed (summarized per woman)
      • Date and result (include right versus left breast): additional views, short-interval follow-up mammogram
      • Date and laterality required, laterality result recorded if available: clinical examination, sonography, fine-needle aspiration, core biopsy, excisional biopsy
    • Pathologic Variables
      • Carcinoma pathology (as obtained in SEER registries)
        • Type of procedure, reporting source, laterality
        • Staging: size, histopathology, grade, tumor size, number of positive nodes, metastasis present (TNM), American Joint Committee on Cancer stage, extension*, nodal involvement* (number examined and postive), tumor sequence*, estrogen and progesterone receptor status*
        • Therapy (data first initiated): surgery, radiation, chemotherapy, hormonal, biologic modification, no surgery reason*
        • Follow-up status*: date of last follow-up, vital status last follow-up*, cause of death
    • Benign pathology*
      • Type of Procedure
      • Reporting source
      • Laterality
      • Histopathology (as recorded and also categorized into major groups: atypical hyperplasia, ductal hyperplasia, fibroadenoma, phyllodes tumor, benign, normal, inconclusive